In chronic myeloid leukemia, BCR-ABL1 activates several pro-survival substrates, including HCK, supporting a role for HCK in BCR-ABL1-induced proliferation and survival. Here, HCK is linked to chronic myelogenous leukemia, BCR-ABL1 positive.